Cargando…
Anti-proliferative therapy for HIV cure: a compound interest approach
In the era of antiretroviral therapy (ART), HIV-1 infection is no longer tantamount to early death. Yet the benefits of treatment are available only to those who can access, afford, and tolerate taking daily pills. True cure is challenged by HIV latency, the ability of chromosomally integrated virus...
Autores principales: | Reeves, Daniel B., Duke, Elizabeth R., Hughes, Sean M., Prlic, Martin, Hladik, Florian, Schiffer, Joshua T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479830/ https://www.ncbi.nlm.nih.gov/pubmed/28638104 http://dx.doi.org/10.1038/s41598-017-04160-3 |
Ejemplares similares
-
Substantial uneven proliferation of CD4(+) T cells during recovery from acute HIV infection is sufficient to explain the observed expanded clones in the HIV reservoir
por: Tettamanti Boshier, Florencia A., et al.
Publicado: (2022) -
A new hypothesis on HIV cure
por: Hladik, Florian
Publicado: (2015) -
A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation
por: Reeves, Daniel B., et al.
Publicado: (2018) -
Interests of the Non-Human Primate Models for HIV Cure Research
por: Terrade, Gauthier, et al.
Publicado: (2021) -
Anti-apoptotic mechanisms of HIV: lessons and novel approaches to curing HIV
por: Cummins, Nathan W., et al.
Publicado: (2012)